CAS
WST icon

Coppell Advisory Solutions’s West Pharmaceutical WST Stock Holding History

Coppell Advisory Solutions’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$2.63K – 1888
2024
Q4 		$2.63K Hold
8
– – ﹤0.01% 1487
2024
Q3 		$2.49K Hold
8
– – ﹤0.01% 1408
2024
Q2 		$2.63K Buy
+8
New +$2.83K ﹤0.01% 1341
2023
Q4 		$2.82K Buy
+8
New +$2.83K ﹤0.01% 1224

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Coppell Advisory Solutions's WST Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 8 shares — an estimated $2.63K sold.

Coppell Advisory Solutions first reported a position in WST in Q4 2023 and held it in 4 quarters. The position peaked at $2.82K in Q4 2023. 713 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 8 West Pharmaceutical shares in Q1 2025, an estimated $2.63K.
  • Coppell Advisory Solutions first reported a position in West Pharmaceutical in Q4 2023 and held it in 4 quarters.
  • Coppell Advisory Solutions's West Pharmaceutical position peaked at $2.82K in Q4 2023.
  • 713 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.